161 related articles for article (PubMed ID: 26970415)
41. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse.
Digesu GA; Khullar V; Cardozo L; Robinson D; Salvatore S
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(3):176-81; discussion 181. PubMed ID: 15875234
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a vision and night driving questionnaire.
Kimlin JA; Black AA; Djaja N; Wood JM
Ophthalmic Physiol Opt; 2016 Jul; 36(4):465-76. PubMed ID: 27350185
[TBL] [Abstract][Full Text] [Related]
43. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30.
Krabbe PF; Peerenboom L; Langenhoff BS; Ruers TJ
Qual Life Res; 2004 Sep; 13(7):1247-53. PubMed ID: 15473503
[TBL] [Abstract][Full Text] [Related]
44. Validation of the EuroQol questionnaire in cardiac rehabilitation.
Schweikert B; Hahmann H; Leidl R
Heart; 2006 Jan; 92(1):62-7. PubMed ID: 15797936
[TBL] [Abstract][Full Text] [Related]
45. [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)].
Boada M; Cejudo JC; Tàrraga L; López OL; Kaufer D
Neurologia; 2002; 17(6):317-23. PubMed ID: 12084358
[TBL] [Abstract][Full Text] [Related]
46. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
47. A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes?
Baber JT; Hiatt JR; Busuttil RW; Agopian VG
J Am Coll Surg; 2014 Oct; 219(4):695-703. PubMed ID: 25065361
[TBL] [Abstract][Full Text] [Related]
48. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
[TBL] [Abstract][Full Text] [Related]
49. Liver transplantation for polycystic liver disease.
Pirenne J; Aerts R; Yoong K; Gunson B; Koshiba T; Fourneau I; Mayer D; Buckels J; Mirza D; Roskams T; Elias E; Nevens F; Fevery J; McMaster P
Liver Transpl; 2001 Mar; 7(3):238-45. PubMed ID: 11244166
[TBL] [Abstract][Full Text] [Related]
50. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
[TBL] [Abstract][Full Text] [Related]
51. Validation of a new simple questionnaire to "estimate ambulation capacity by history" (EACH) in patients with claudication.
Ouedraogo N; Mahe G; Marchand J; Saïdi K; Leftheriotis G; Abraham P
J Vasc Surg; 2011 Jul; 54(1):133-8. PubMed ID: 21334169
[TBL] [Abstract][Full Text] [Related]
52. [Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire].
Ruiz Díaz MA; Suárez Parga JM; Pardo Merino A; García Vargas M; Pascual Renedo V
Gastroenterol Hepatol; 2009 Jan; 32(1):9-21. PubMed ID: 19174094
[TBL] [Abstract][Full Text] [Related]
53. Development and psychometric validation of the intermittent self-catheterization questionnaire.
Pinder B; Lloyd AJ; Elwick H; Denys P; Marley J; Bonniaud V
Clin Ther; 2012 Dec; 34(12):2302-13. PubMed ID: 23178033
[TBL] [Abstract][Full Text] [Related]
54. Management of nonparasitic hepatic cysts.
Mazza OM; Fernandez DL; Pekolj J; Pfaffen G; Sanchez Clariá R; Molmenti EP; de Santibañes E
J Am Coll Surg; 2009 Dec; 209(6):733-9. PubMed ID: 19959042
[TBL] [Abstract][Full Text] [Related]
55. Long-term results of liver transplantation for polycystic liver disease: Single-center experience in China.
Ding F; Tang H; Zhao H; Feng X; Yang Y; Chen GH; Chen WJ; Xu C
Exp Ther Med; 2019 May; 17(5):4183-4189. PubMed ID: 31007749
[TBL] [Abstract][Full Text] [Related]
56. Higher need for polycystic liver disease therapy in female patients: Sex-specific association between liver volume and need for therapy.
Barten TRM; Atsma F; van der Meer AJ; Gansevoort R; Nevens F; Drenth JPH; Gevers TJG
Hepatology; 2024 Mar; 79(3):551-559. PubMed ID: 37725713
[TBL] [Abstract][Full Text] [Related]
57. Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly.
Barten TRM; Bökkerink RMP; Venderink W; Gevers TJG; Ten Broek RPG; Drenth JPH
Liver Int; 2022 Apr; 42(4):871-878. PubMed ID: 35129293
[TBL] [Abstract][Full Text] [Related]
58. Polycystic Liver Disease with Huge Infected Cyst Displacing the Pancreas, Inferior Vena Cava and Right Kidney.
Al-Harthi AH; Khan PM; Al Marwani M
Saudi J Med Med Sci; 2016; 4(3):222-224. PubMed ID: 30787735
[TBL] [Abstract][Full Text] [Related]
59. Current treatment status of polycystic liver disease in Japan.
Ogawa K; Fukunaga K; Takeuchi T; Kawagishi N; Ubara Y; Kudo M; Ohkohchi N
Hepatol Res; 2014 Oct; 44(11):1110-8. PubMed ID: 24308726
[TBL] [Abstract][Full Text] [Related]
60. Kidney symptom questionnaire: Development, content validation and relationship with quality of life.
Brown SA; Tyrer F; Clarke AL; Lloyd-Davies LH; Niyi-Odumosu FA; Nah RGQ; Stein AG; Tarrant C; Smith AC
J Ren Care; 2018 May; ():. PubMed ID: 29797783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
